P

Prisma Health | Midlands Clinical Research Unit

Research site

(Unclaimed)

Location

9 Medical Park Drive, Suite 400, Columbia, South Carolina, United States of America

Site insights

Top conditions

Top treatments

L-Arginine

Vitamin D

Astaxanthin

Vitamin C

Iron

Diuretic

Parent organization

This site is a part of Prisma Health

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 12 total trials

Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study

Prospective, randomized, open-label, international, multi-center clinical study to evaluate the safety and efficacy of the AccuCinch Ventricular Rest...

Enrolling

Dilated Cardiomyopathy

Heart Failure With Reduced Ejection Fraction (HFrEF)

Device: AccuCinch Ventricular Restoration System

Drug: Guideline-Directed Medical Therapy

Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study (FROST-HF)

The purpose of this clinical study is to assess the safety and effectiveness of the Atrial Flow Regulator in the treatment of subjects, 18 years of a...

Active, not recruiting

Heart Failure With Preserved Ejection Fraction (HFpEF)

Heart Failure With Reduced Ejection Fraction (HFrEF)

Device: Atrial Flow Regulator

Device: Sham Comparator

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS) (FASTR)

The objective of this study is to prospectively compare decongestive therapy administered by the Reprieve DMS system to Optimal Diuretic Therapy (ODT...

Enrolling

Acute Decompensated Heart Failure

Device: Reprieve Decongestion Management System

Drug: Diuretic

Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial (DTU-STEMI)

The purpose of this research study is to evaluate whether using the the IMPELLA® CP System temporary circulatory assist device for 30 minutes prior t...

Enrolling

ST Elevation (STEMI) Myocardial Infarction of Anterior Wall

Device: Impella CP® placement prior to reperfusion with Primary PCI